Supplementary table 2 from A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma
| Autor: | Craig C. Hofmeister, Michael R. Grever, Flavia Pichiorri, Ashley E. Rosko, Yvonne A. Efebera, Don M. Benson, Gregory B. Lesinski, Thomas Mace, Andrew Stiff, Gerard J. Nuovo, Douglas W. Sborov |
|---|---|
| Rok vydání: | 2023 |
| Popis: | Supplementary table 2. Five patients experienced at least grade 2 adverse events. Two of the 5 patients received at least 4 cycles of treatment, and the associated adverse events were noted after cycle 1. All cytopenias resolved prior to the completion of the cycle that adverse event occurred. Abbreviations: DL = dose level, m-protein = monoclonal protein, CXDX = cycle X, day X, NA = not available. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|